Central nervous system manifestations of monogenic autoinflammatory disorders and the neurotropic features of SARS-CoV-2: Drawing the parallels
Central nervous system (CNS) involvement in monogenic autoinflammatory disorders (AID) is increasingly recognized and can be life threatening. Therefore, a low threshold to consider CNS disease should be maintained in patients with systemic inflammation. Hyperinflammation is also a key feature of se...
Main Authors: | Thomas Renson, Lorraine Hamiwka, Susanne Benseler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.931179/full |
Similar Items
-
Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases
by: Alex Fonollosa, et al.
Published: (2024-02-01) -
Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review
by: Zhivana Boyadzhieva, et al.
Published: (2022-06-01) -
Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
by: Ignasi Figueras-Nart, et al.
Published: (2019-10-01) -
Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood
by: Tatjana Welzel, et al.
Published: (2021-03-01) -
Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study
by: Caihui Zhang, et al.
Published: (2023-10-01)